Study Stopped
Lake of personnel
Study of Prognostic Factors in Interventional Rhythmology
1 other identifier
observational
2,805
1 country
1
Brief Summary
Develop a prospective register assessing the short- and long-term complications of patients undergoing interventional rhythm
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2017
CompletedFirst Submitted
Initial submission to the registry
March 17, 2017
CompletedFirst Posted
Study publicly available on registry
April 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2020
CompletedFebruary 6, 2025
February 1, 2025
3 years
March 17, 2017
February 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The occurrence of adverse clinical events
The occurrence of the following adverse clinical events: infectious, rhythmic complications, hemodynamic, mortality any causes and cardiovascular post--interventional and in the length-course
5 years
Secondary Outcomes (7)
duration of intervention
Day 1
dose of X-radiation used
Day1
volume of used contrast agent
Day1
duration of hospitalization
3 months
need for reoperation
5 years
- +2 more secondary outcomes
Interventions
The follow-up will take place at 3 months postoperatively, then at 1 year and then annually for 5 years.
Eligibility Criteria
Patient that must undergo a gesture of interventional rythmology in the Department of Cardiology of the CHRU of Brest
You may qualify if:
- Patient to undergo:
- Implantation of a cardiac pacemaker or cardiac defibrillator or
- Extraction of pacemaker / defibrillator housing or probes or
- Realization of a radiofrequency / cryo-ablation:
- Atrial fibrillation
- Focus of ventricular tachycardia
- An accessory or
- Any electrophysiological exploration or
- Installation of Holter implantable or
- Left auricular closure percutaneously Having formulated its non-opposition
You may not qualify if:
- Minor
- Patient's refusal
- Patients under legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU Brest
Brest, 29200, France
Study Officials
- PRINCIPAL INVESTIGATOR
Jacques Mansourati, Professor
University Hospital, Brest
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2017
First Posted
April 4, 2017
Study Start
March 7, 2017
Primary Completion
March 13, 2020
Study Completion
March 13, 2020
Last Updated
February 6, 2025
Record last verified: 2025-02